WO1997015399A1 - Cell separation system for biological fluids like blood - Google Patents

Cell separation system for biological fluids like blood Download PDF

Info

Publication number
WO1997015399A1
WO1997015399A1 PCT/IB1996/000771 IB9600771W WO9715399A1 WO 1997015399 A1 WO1997015399 A1 WO 1997015399A1 IB 9600771 W IB9600771 W IB 9600771W WO 9715399 A1 WO9715399 A1 WO 9715399A1
Authority
WO
WIPO (PCT)
Prior art keywords
processing chamber
biological fluid
piston
fluid
centrifugal
Prior art date
Application number
PCT/IB1996/000771
Other languages
French (fr)
Inventor
Claude Fell
Original Assignee
Claude Fell
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Claude Fell filed Critical Claude Fell
Priority to EP96924105A priority Critical patent/EP0912250B1/en
Priority to US09/147,117 priority patent/US6123655A/en
Priority to DE69605062T priority patent/DE69605062T2/en
Priority to AU64677/96A priority patent/AU6467796A/en
Publication of WO1997015399A1 publication Critical patent/WO1997015399A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3693Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits using separation based on different densities of components, e.g. centrifuging
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/02Blood transfusion apparatus
    • A61M1/0209Multiple bag systems for separating or storing blood components
    • A61M1/0218Multiple bag systems for separating or storing blood components with filters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3621Extra-corporeal blood circuits
    • A61M1/3627Degassing devices; Buffer reservoirs; Drip chambers; Blood filters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3693Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits using separation based on different densities of components, e.g. centrifuging
    • A61M1/3696Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits using separation based on different densities of components, e.g. centrifuging with means for adding or withdrawing liquid substances during the centrifugation, e.g. continuous centrifugation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3693Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits using separation based on different densities of components, e.g. centrifuging
    • A61M1/3698Expressing processed fluid out from the turning rotor using another fluid compressing the treatment chamber; Variable volume rotors
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B04CENTRIFUGAL APPARATUS OR MACHINES FOR CARRYING-OUT PHYSICAL OR CHEMICAL PROCESSES
    • B04BCENTRIFUGES
    • B04B1/00Centrifuges with rotary bowls provided with solid jackets for separating predominantly liquid mixtures with or without solid particles
    • B04B1/02Centrifuges with rotary bowls provided with solid jackets for separating predominantly liquid mixtures with or without solid particles without inserted separating walls
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B04CENTRIFUGAL APPARATUS OR MACHINES FOR CARRYING-OUT PHYSICAL OR CHEMICAL PROCESSES
    • B04BCENTRIFUGES
    • B04B5/00Other centrifuges
    • B04B5/04Radial chamber apparatus for separating predominantly liquid mixtures, e.g. butyrometers
    • B04B5/0442Radial chamber apparatus for separating predominantly liquid mixtures, e.g. butyrometers with means for adding or withdrawing liquid substances during the centrifugation, e.g. continuous centrifugation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3692Washing or rinsing blood or blood constituents
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B04CENTRIFUGAL APPARATUS OR MACHINES FOR CARRYING-OUT PHYSICAL OR CHEMICAL PROCESSES
    • B04BCENTRIFUGES
    • B04B5/00Other centrifuges
    • B04B5/04Radial chamber apparatus for separating predominantly liquid mixtures, e.g. butyrometers
    • B04B5/0442Radial chamber apparatus for separating predominantly liquid mixtures, e.g. butyrometers with means for adding or withdrawing liquid substances during the centrifugation, e.g. continuous centrifugation
    • B04B2005/0485Radial chamber apparatus for separating predominantly liquid mixtures, e.g. butyrometers with means for adding or withdrawing liquid substances during the centrifugation, e.g. continuous centrifugation with a displaceable piston in the centrifuge chamber

Definitions

  • This invention relates to the automated on line collection and separation of a biological fluid like blood into its sub-components, and relates more specifically to a functionally closed centrifugation chamber that extracts sub-components according to their density and size, such as platelets, plasma or red cells from whole blood, and to the methods for carrying out such a separation.
  • Whole blood consists essentially of red blood cells, white blood cells, platelets and plasma. These components are required for different therapeutic usage and therefore whole blood resulting from a donation is generally processed in order to extract them. This is done in two steps.
  • a first step consists in collecting whole blood from a donor into a primary bag containing an anticoagulant solution.
  • a typical blood donation lasts between 5-10 min., to collect a fixed volume generally of 450 ml of whole blood. This fixed volume excludes a certain range of the donor population due to risks of hypovolemia, as standard blood bank practices limit collection to 15% of the total blood volume of a donor. Once the collection is completed, the donor is released and the second step can be initiated.
  • haemapheresis technology in whole blood donation. This technique consists of drawing and extracting on line one or more blood components while a donation is performed, and returning the remaining constituents to the donor.
  • haemapheresis systems preclude their use by transfusion centers for routine whole blood collection.
  • the invention therefore proposes an improved portable and disposable centrifugal apparatus whose processing chamber is of variable volume. It can therefore process a variable quantity of biological fluid, even down to very small quantities.
  • this variation of volume can be achieved with a piston which acts as a pump, providing a unique combination of a processing chamber with integrated pump.
  • the invention also concerns the overall centrifugal apparatus and instrumentation cooperating with the processing chamber of variable volume, as well as methods of processing biological fluids in this apparatus, in particular the collection and separation of whole blood.
  • This new apparatus and system enable a fully automated online collection and separation of biological fluids even in very small quantities, opening up new perspectives in therapeutic extracorporeal processing applications. Its compactness and high portability make it ideal for mobile applications.
  • the main components of the system are easy to manufacture from inexpensive and environmentally friendly materials, and are fully disposable. No known device meets these requirements.
  • the system described here allows the transfer of a biological fluid, like blood, in a functionally closed processing chamber, and its separation into sub- constituents and extraction into separate blood containers.
  • the heart of the system is a centrifugal processing chamber which functions like a spinning syringe. Its volume is variable, preferably through a piston which can be actuated by vacuum or pressure through a port located at the bottom of the processing chamber.
  • This provides an efficient system combining a centrifugation chamber accommodating any processing volumes, with a piston pump reducing the stressing effect on cells, unlike peristaltic pumps. No additional external pump is required for the transfer of the biological fluid or extraction of its components into or out of the processing chamber. It is however possible to use peristaltic pumps, as explained below.
  • Another aspect of the invention is a disposable set for collecting and separating selected quantities of biological fluids, comprising a centrifugal processing chamber as described whose inlet/outlet is connected to a means, such as phlebotomy needle, for collecting biological fluid, and to a plurality of containers, such as flexible bags, for receiving the separated components of the biological fluid.
  • the instrumentation associated with such a disposable set is lightweight and compact. It is easily portable.
  • the processing chamber thus is advantageously connected, as part of a disposable set including disposable bags and tubing lines, by means of a functionally closed rotating seal. The whole set is discarded after use, to avoid the likelihood of transmission of infectious agents.
  • the centrifugal processing chamber has a variable volume comprised between a minimum (e.g. 0 ml) up to a maximum which corresponds to the total volume of the chamber (e.g. 500 ml).
  • a minimum e.g. 0 ml
  • a maximum which corresponds to the total volume of the chamber (e.g. 500 ml).
  • the variation of the centrifuge chamber volume is usually performed by a piston that can move freely in the rotor of the processing chamber.
  • the piston movement is advantageously achieved by the injection of a vacuum or air under pressure through a central port located on the bottom of the processing chamber.
  • Such air port can be protected by a bacterial filter and is in tight communication with a centrifuge chuck assembly driving the processing chamber.
  • the processing chamber can have only one fluid communication port which is used both for the biological fluid transfer and the extraction of the components.
  • Multi-port communication is also possible to provide for separate removal of different components.
  • the transfer of biological fluid into the processing chamber or the extraction of the sub-components does not require any external pump and can be accomplished by the downward and upward movement of a piston into the chamber. Moreover, the volume of the biological fluid processed and volumes of the sub-components extracted can be exactly metered by monitoring the position of the piston into the chamber, like a graduated syringe.
  • the centrifugal processing chamber is self-balanced and therefore can be driven by a compact and lightweight assembly.
  • the centrifugal processing chamber advantageously has an air pathway allowing movement of the piston without any physical contact of the piston with the centrifuge driving mechanism.
  • the above-mentioned disposable set is associated with instrumentation which allows processing and separation to take place.
  • the instrumentation is incorporated in a lightweight and portable unit including a centrifuge spinning the processing chamber and valves for directing the components to their appropriate collection container. It is equipped with a sensor system whose information is sent to a central microprocessor unit, allowing full automation of the process.
  • the description relates principally to the processing and separation of whole blood but the described separation technology can apply to other types of applications like haemapheresis, blood autotransfusion, blood cell washing, or special biological cells isolation like stem cells or islets of Langerhans.
  • this new cell separation system offers significant advantages which include :
  • the volume of the processing chamber is variable between 0 and the total volume of the chamber (e.g. 500 ml) . It can adapt to any type of donor or patient by suppressing the risks of hypovolemia. It opens up new perspectives in extracorporeal blood treatment for children, for instance. • No pumps are required, but can be used if wanted.
  • the technology is based on conventional medical grade material and manufacturing techniques, which results in a very cost-effective system.
  • FIG. 1 is a schematic side elevation and cross-sectional view of a processing chamber according to the invention installed in a centrifugal assembly.
  • FIG. 2 is a detailed cross-sectional view of the centrifugal processing chamber illustrating the various sedimentation layers of blood components.
  • - Fig. 3 illustrates in a schematic form the disposable set used for the processing and separation of blood.
  • - Figs. 4.1 to 4.6 are functional diagrams showing the various steps of whole blood separation using a disposable set including a processing chamber according to the invention.
  • FIG. 5 is a perspective view of a cabinet containing instrumentation for controlling the processing.
  • FIG. 6 is a schematic side elevation and cross-sectional view of a centrifugal assembly.
  • FIG. 7 schematically shows an arrangement for controlling pressure in the processing chamber when it is installed in the centrifuge assembly.
  • FIG. 8 is a schematic side elevation and cross-sectional view of the upper part of a dual port processing chamber.
  • FIG. 9 is a schematic side elevation and cross-sectional view of an extended distribution disk allowing heavier matter to exit the processing chamber first.
  • FIG. 10 illustrates in schematic form a system using peristaltic pumps as a means to introduce and extract biological fluids into and out of the processing chamber.
  • FIG. 11 illustrates in schematic form a system for intra-operative blood autotransfusion based on the processing chamber with variable volume.
  • the processing chamber 13 in accordance with the embodiment of the invention shown in Figs. 1 and 2 comprises a rotor 4 having a cylindrical shape, in which a piston 5 can move upwards or downwards.
  • a variable separation space 12 is defined between the upper end of the rotor 4 and the piston 5.
  • An inlet/outlet port 2 is located through the upper axis of the rotor 4. It is used both for the introduction of the biological fluid to separate and for the extraction of the separated components out of the chamber 13.
  • the inlet/outlet port 2 is terminated inside the separation space 12 by a disk 3 with passing holes 6 at its lower end.
  • a rotating seal 1 is located at the other end of the inlet/outlet port 2, allowing the connection of tubing lines.
  • Below the piston 5, the bottom cap 9 of rotor 4 has a communication port 7 for air through a central aperture equipped with a bacterial filter 8.
  • the rotor 4 is made of a rigid injection molded plastic.
  • a preferable material is polycarbonate or polypropylene which can withstand autoclave sterilization.
  • the upper inlet/outlet port 2 is shown as a separate part fitted on the rotor 4, but it could be an integral part of it .
  • the piston 5 is made of a generally cylindrical disk and is provided with peripheral grooves for O-rings 10. The tightness of these O-rings is chosen such that the piston 5 can be moved for example with vacuum/pressure values comprised in the range between -0.5/+2 bar.
  • This pneumatic embodiment avoids any physical contact between the piston 5 and the associated instrumentation used to drive the processing chamber 13.
  • the bacterial filter 8 ensures that no contamination can be introduced by the air injected to move the piston. Its mesh size is generally about 0.2 microns. It should be noted that the biological fluids never come in contact with the vacuum/pressure space 11 and the bacterial filter 8 provides an additional level of system integrity.
  • Centrifugation generally starts when the procedure is initiated, although it can begin at a later stage when the processing chamber 13 is partially or totally filled. Initially located in the upper part of rotor 4, the piston 5 will move downward under the effect of the vacuum applied in the vacuum/pressure space 11 through the air communication port 7.
  • the vacuum can be provided through an external air pump, connected to the central axle of the centrifuge driving the processing chamber 13.
  • the separation space 12 is variable and is comprised between a minimum volume and a maximum corresponding to the volume of the rotor 4. Therefore, minimal quantities of biological fluids can be separated, starting from 10 ml upwards.
  • the biological fluid passes through the rotating seal 1 and penetrates into separation space 12. Its transfer is further helped by an effect of centrifuge pumping, where the liquid introduced under rotation explains a pressure on piston 5 that increases with the centrifuge speed.
  • centrifuge pumping By selecting properly the rotational speed when filling, only minimal or even no vacuum is necessary to move the piston 5 down. Centrifugal separation occurs in the space 12 and the piston 5 moves slowly down in order to avoid any disturbance of the sedimentation. Its speed accommodates the donor vein capability by reading the in-line pressure measured in tubing 94 (Fig.
  • Filling rates range between 50-100 ml/min., typically.
  • the speed is selected according to a pressure reading taken by filter 95 which acts as a manometer (Figs. 3 and 7).
  • the residence time and rotational rate are selected such that heavier cellular matter is concentrated at the outer radial region.
  • the centrifuged biological fluid deposits in distinct layers, with lighter matter moving to the inner region of the separation space 12.
  • these layers are packed red cells 22 on the outside, an intermediate layer 21 of platelets/white cells generally called buffy-coat, and plasma 20 inside.
  • the volume of biological fluid introduced into the processing chamber 13 or the volumes of the extracted components can be exactly measured by monitoring the position of the piston 5 during the process, like a graduated syringe.
  • Fig. 3 illustrates an application for whole blood separation. It will be understood however that this is only one example of application of the cell separator and method of the present invention, and other specific applications can be carried out utilizing the invention system.
  • the disposable set used for this separation comprises a centrifugal processing chamber 13 (like the processing chamber of Figs. 1 and 2) connected to a set of tubing lines and bags.
  • a schematically-indicated phlebotomy needle 82 is connected to a tubing line 93 which connects the processing chamber 13 to a plasma bag 85, a buffy-coat bag 84 and a red cell bag 83.
  • a portion of so-called pigtail tubing 94 terminated with a bacterial filter 95 is connected to the inlet tubing of the processing chamber 13 for pressure measurement (see also Fig. 7).
  • Anticoagulant like CPD can be contained initially in the plasma bag 83, for transfer into the processing chamber 13 when the procedure is initiated. This is only one way the anticoagulant can be transferred. Alternatives would be to have the processing chamber 13 pre-filled with anticoagulant, or to have an additional bag containing only the anticoagulant.
  • the red cell bag 83 may contain an additive solution to extend the shelf life of erythrocytes.
  • An optional additional bag 92 contains a special substance for further transfer into the appropriate blood component bags in order to inactivate virus.
  • Another possibility of the system consists in filtering on line components for leukocytes removal, using a filter 91 for the collection of leukocyte-free red cells.
  • Valves 86-90 are associated with the tubing line 93, as illustrated in Fig. 3. These valves are located on the instrument as indicated by reference 102 on Fig. 5, and serve to open/close the tubing lines according to the procedure step.
  • the bags 83,84,85,92 are not exposed to a stress-causing G force as presently with the batch centrifugation process.
  • the options for design and material choice of the bags are therefore extensive. This facilitates the compliance to regulatory standards for having an environmental friendly disposable material.
  • the separation of whole blood is sequential and components of increasing density and size are collected.
  • Centrifugation can start at any time from step 1, 2 or 3.
  • the separation steps are :
  • Step 1 Anticoagulant priming of the processing chamber
  • Valve 89 is open and anticoagulant is pumped out of plasma bag 85. This step can be avoided if the processing chamber is pre-filled with the anticoagulant solution.
  • Step 2 Whole blood collection, by moving the piston 5 downwards and opening valve 86.
  • Step 3 The piston 5 reaches the bottom of the processing chamber 13, or when stopped by the operator or at a pre-set value. Collection stops. The phlebotomy needle 82 can be disconnected.
  • Step 4 Extraction of plasma, by moving the piston 5 upwards. Donor valve 86 is closed, plasma valve 89 is open. Plasma is collected into bag 85.
  • Step 5 Buffy-coat extraction, by moving slowly the piston 5 upwards. Plasma valve 89 is closed and buffy-coat valve 88 is open. Buffy-coat is collected into bag 84.
  • Step 6 Red cell extraction, by moving the piston 5 upwards. Centrifugation is stopped, although it can be continued if differential separation of red cell collection is desired. Buffy-coat valve 88 is closed and red cell valve 87 is open. Packed red cells are collected into bag 83. Extraction of red cells is completed when the piston reaches the top of the processing chamber
  • the centrifuge drive unit is illustrated in Fig. 1 with the processing chamber fitted, in Fig. 6 without the processing chamber, and in Fig. 7 with the associated arrangement for controlling pressure. It should be noted that although shown vertically it can be operated in any position.
  • a chuck 46 of generally cylindrical shape with a longitudinal hollow axle 43 underneath is used to drive the centrifuge processing chamber 13.
  • the chuck 46 has an O-ring 51 mounted in an aperture in its bottom.
  • the O-ring 51 frictionally engages the lower outer portion of the air communication port 7 of the inserted processing chamber 13, providing fluid-tight communication with a vacuum/pressure port 36 through which vaccum or air under pressure is supplied from an external source (see Fig. 7).
  • a bearing assembly 35 ensures proper alignment of the chuck 46.
  • Seam rings 47 are located on each side of the bearing assembly 35. Between the two bearings of bearing assembly 35, the axle 43 has a passing hole 44 that communicates with the vacuum/pressure port
  • the chuck 46 is housed within a stationary cylindrical housing 32, which is mounted on a support plate 33.
  • the housing 32 carries a closing cover 31 on its top, along with an associated rotating seal holder 48.
  • the cover 31 is composed of two symmetric planar and semicircular half-discs, that can be moved apart and together so the rotating seal holder 48 can grip the rotating seal 1.
  • a proximity sensor 50 is secured in the support plate 33 and measures the displacement of the piston 5 for volume and flow rate control. For example, this sensor 50 passes an optical beam through an aperture 49 in the chuck bottom, and which is reflected back by the piston 5.
  • this sensor 50 passes an optical beam through an aperture 49 in the chuck bottom, and which is reflected back by the piston 5.
  • infrared Doppler sensors inductive or Hall effect sensors could be used.
  • the pressure/vacuum value in the space 11 is constantly measured by a pressure sensor 72 connected to line 71 (Fig. 7) during operation.
  • the pressure in tubing line 94 is also measured by an in-line pressure sensor 73.
  • This information is fed-back to a control system 74 controlling a compressor driver 75.
  • An algorithm adjusts the power of compressor 70 according to the values of these pressure readings.
  • the centrifuge is mounted in a cabinet (see Fig. 5) on three cylindrical feet 41.
  • An electrical motor 39 enclosed in a housing 40 with a tachometer 42 fitted on its lower end is attached through a coupling 38 to the chuck axle 43.
  • the rotation speed ranges between about 3000-10000 rpm depending on the application.
  • Motor 39 is mounted on a support shaft plate 37 which is attached to the support plate 33 by shaft housing 34.
  • the processing chamber 13 being self-balanced, the whole centrifuge assembly herein described can be made very light and compact.
  • the instrumentation is composed of a cabinet 103 housing a centrifuge 100. It is lightweight and compact which makes this device especially useful for portable applications.
  • the cabinet 103 is made of a reinforced material like ABS.
  • the centrifuge 100 drives the processing chamber 13 at speeds up to 10000 rpm.
  • Valves 102 i.e. corresponding to 86-90 of Fig. 3 equipped with position sensors are located on the top of the cabinet housing. These valves clamp the proper tubing lines (Fig. 3) for collecting the separated products. Sensors are provided to monitor the pressure inside the processing chamber 13 and piston chambers.
  • An optical sensor 101 controls the appropriate collection of blood constituents like plasma, platelets or red cells and commutes the valves 102 according to the desired separation steps illustrated in Fig.
  • An ultrasonic air detector 106 monitors the presence of air in the donor line.
  • the cover 104 provides access to the operator-controlled instrumentation. When the cover 104 is open, it is inclined at a 20° angle for ease of viewing.
  • the cover 104 has a panel 107 mounted on the inside with a display and control functions module 105 incorporated therein.
  • Fig. 8 shows a dual port configuration allowing a continuous operation, where collection of the desired component can take place while the product to be separated is introduced into the processing chamber.
  • an inlet port 25 leads onto a distribution disk 27 located at the upper end of chamber 13, so that incoming biological fluid is directed, as indicated by the arrows, to the disk's periphery where the fluid is ejected with the maximum centrifugal force against the chamber wall.
  • An outlet port 26 is located in extension of a central outlet tube 28 leading into the separation space through the center of the distribution disk 27. Consequently, the separated components exit centrally via this tube 28 and outlet port 26, also as indicated by arrows.
  • continuous operation can be performed using one external pump like the peristaltic pump 110 (Fig. 10) for transferring the biological fluid into chamber 13 via port 25 and distribution disk 27.
  • the piston 5 moves in response to the volume of fluid introduced until the bottom of the chamber is reached, or until stopped at an intermediate position.
  • Two methods can be chosen for extracting the components out of the chamber 13 via tube 28 and port 26. The first consists in continuing filling the chamber so the packed red cells will gradually push the other components out of the chamber 13. The other consists of stopping the peristaltic pump 110, moving the piston 5 up, and the collection of components will be done as illustrated in steps 4-4 to 4-6 of Fig. 4.
  • a multiport system could also be used, where more than one component could be collected out of the chamber simultaneously.
  • the piston 5 is driven by vacuum/compressed air. It would equally be possible to drive the piston by mechanical, electromagnetic or hydraulic means, possibly under electronic control. In the case of hydraulic means, the piston 5 can be moved by sterile fluid that can be pumped in and out of the space 11 of the processing chamber 13.
  • the rotor 4 of processing chamber 13 can be made of a flexible material like a soft bag which, during rotation, would be supported by the centrifuge chuck 46 so as to maintain a cylindrical shape.
  • FIG. 9 Another variation shown in Fig. 9 consists of having the distribution disk 3 of a diameter close to the internal diameter of rotor 4. When the separated components are expressed out of chamber 13, this would allow the higher density cells like red cells to be sorted first, which would be of interest in red cell autotransfusion for example.
  • FIG. 10 Another variation shown in Fig. 10 consists of transferring fluids in and out of the processing chamber 13 by means of peristaltic pumps 110 and 111 acting on the tubing line 93, respectively to deliver blood into the processing chamber 13 and to remove the separated components from the processing chamber 13.
  • the piston 5 does not act as a pump, but only as a means to vary the volume of the separation space 12. Consequently it is no longer necessary to use pneumatic means, or any other equivalent means, to move the piston 5.
  • the use of peristaltic pumps is recommended for carrying out haemapheresis procedures, in particular using the dual port arrangement of Fig. 8.
  • Another variation consists of having the upper part of the rotor 4, as well as the upper part of the piston 5, of a conical shape in order to allow a smoother fluid path out of the processing chamber.
  • the apparatus of the present invention is particularly suited for the separation and collection of blood components. As described above, a main application is in-line whole blood separation. Other applications include :
  • the instrumentation should incorporate the necessary components and modules to manage the reinfusion procedure. Proper anticoagulation should also be provided at the needle site, with proportional mixing to ensure that no clot formation will occur in the line.
  • Post-operative blood autotransfusion would also be possible using the processing chamber 13 in a static mode where only the piston 5 would be moved for establishing the drainage vacuum. Upon filling the processing chamber 13 or completion of the drainage period, centrifugation of the processing chamber 13 would be started and shortly afterwards the piston 5 lifted in order to express the supernatant. Red cells could then be recovered or washed as described above for intraoperative autotransfusion.
  • the system will function in a batch process and the cells, contained in their physiological medium, would be introduced by moving the piston down.
  • the targeted cells will be expressed out of the processing chamber 13 into the appropriate collection bag. The process is repeated until the initial product has been processed, at which time an ultimate cell purification process can be done by reintroducing the collected cells into the chamber for a final concentration and expressing them into the collection bag.
  • the system can be used for the separation of other physiological fluids such as medium containing islets of Langerhans, or certain type of tumoral cells for further biotechnological manipulations.

Abstract

This invention proposes an improved portable and disposable centrifugal apparatus having a centrifugal processing chamber (13) of variable dimensions that can process a variable quantity of biological fluid, even down to very small quantities, by displacement of a movable member such as a piston (5). The invention also concerns the overall centrifugal apparatus and instrumentation cooperating with the processing chamber (13), a disposable set comprising the processing chamber (13) and a set of collection bags, as well as methods of processing biological fluids in this apparatus, in particular the collection and separation of whole blood.

Description

CELL SEPARATION SYSTEM FOR BIOLOGICAL FLUIDS LIKE BLOOD
FIELD OF THE INVENTION
This invention relates to the automated on line collection and separation of a biological fluid like blood into its sub-components, and relates more specifically to a functionally closed centrifugation chamber that extracts sub-components according to their density and size, such as platelets, plasma or red cells from whole blood, and to the methods for carrying out such a separation.
BACKGROUND OF THE INVENTION Whole blood consists essentially of red blood cells, white blood cells, platelets and plasma. These components are required for different therapeutic usage and therefore whole blood resulting from a donation is generally processed in order to extract them. This is done in two steps. A first step consists in collecting whole blood from a donor into a primary bag containing an anticoagulant solution. A typical blood donation lasts between 5-10 min., to collect a fixed volume generally of 450 ml of whole blood. This fixed volume excludes a certain range of the donor population due to risks of hypovolemia, as standard blood bank practices limit collection to 15% of the total blood volume of a donor. Once the collection is completed, the donor is released and the second step can be initiated. It consists in separating the blood into its sub-components through a batch process. This is done by spinning the blood bag for a period of about 10 minutes in a large refrigerated centrifuge. The main blood constituents, erythrocytes, platelets and white cells, plasma having sedimented and formed distinct layers, are then expressed sequentially by a manual extractor in different satellite bags attached to the primary bag.
More recently, automated extractors have been introduced in order to facilitate the manipulation. Nevertheless, the whole process remains laborious and requires the separation to occur within a certain time frame to guarantee the quality of the blood components. This complicates the logistics, especially considering that most blood donations are performed in decentralized locations where no batch processing capabilities exist.
This method has been practiced since the widespread use of the disposable plastic bags for collecting blood in the 1970' s and has not evolved significantly since then. Some attempts have been made to apply haemapheresis technology in whole blood donation. This technique consists of drawing and extracting on line one or more blood components while a donation is performed, and returning the remaining constituents to the donor. However, the complexity and costs of haemapheresis systems preclude their use by transfusion centers for routine whole blood collection.
There have been various proposals for portable, disposable, centrifugal apparatus usually with collapsible bags, for example as in US Patents Nos 3,737,096, or 4,303,193, or with a rigid walled bowl as in US Patent No 4 889,524. These devices all have a minimum fixed holding volume which requires a minimum volume usually of about 250 ml to be processed before any components can be collected.
There remains a widespread need for a system that, during blood collection, will automatically separate the different components of whole blood that are differentiable in density and size, with a simple, low cost, disposable unit. DISCLOSURE OF THE INVENTION
As set out in the claims, the invention therefore proposes an improved portable and disposable centrifugal apparatus whose processing chamber is of variable volume. It can therefore process a variable quantity of biological fluid, even down to very small quantities. In some embodiments, this variation of volume can be achieved with a piston which acts as a pump, providing a unique combination of a processing chamber with integrated pump. The invention also concerns the overall centrifugal apparatus and instrumentation cooperating with the processing chamber of variable volume, as well as methods of processing biological fluids in this apparatus, in particular the collection and separation of whole blood. This new apparatus and system enable a fully automated online collection and separation of biological fluids even in very small quantities, opening up new perspectives in therapeutic extracorporeal processing applications. Its compactness and high portability make it ideal for mobile applications. The main components of the system are easy to manufacture from inexpensive and environmentally friendly materials, and are fully disposable. No known device meets these requirements. The system described here allows the transfer of a biological fluid, like blood, in a functionally closed processing chamber, and its separation into sub- constituents and extraction into separate blood containers. The heart of the system is a centrifugal processing chamber which functions like a spinning syringe. Its volume is variable, preferably through a piston which can be actuated by vacuum or pressure through a port located at the bottom of the processing chamber. This provides an efficient system combining a centrifugation chamber accommodating any processing volumes, with a piston pump reducing the stressing effect on cells, unlike peristaltic pumps. No additional external pump is required for the transfer of the biological fluid or extraction of its components into or out of the processing chamber. It is however possible to use peristaltic pumps, as explained below.
Another aspect of the invention is a disposable set for collecting and separating selected quantities of biological fluids, comprising a centrifugal processing chamber as described whose inlet/outlet is connected to a means, such as phlebotomy needle, for collecting biological fluid, and to a plurality of containers, such as flexible bags, for receiving the separated components of the biological fluid. The instrumentation associated with such a disposable set is lightweight and compact. It is easily portable. The processing chamber thus is advantageously connected, as part of a disposable set including disposable bags and tubing lines, by means of a functionally closed rotating seal. The whole set is discarded after use, to avoid the likelihood of transmission of infectious agents.
The centrifugal processing chamber has a variable volume comprised between a minimum (e.g. 0 ml) up to a maximum which corresponds to the total volume of the chamber (e.g. 500 ml). The system thus allows the separation of a minimal quantity of biological fluids starting from 10 ml upwards. As the maximum quantity that one can transfer into the processing chamber corresponds to the total volume of the chamber, this provides a self-built safety against risks of exceeding normal extracorporeal volumes.
The variation of the centrifuge chamber volume is usually performed by a piston that can move freely in the rotor of the processing chamber. The piston movement is advantageously achieved by the injection of a vacuum or air under pressure through a central port located on the bottom of the processing chamber. Such air port can be protected by a bacterial filter and is in tight communication with a centrifuge chuck assembly driving the processing chamber.
The processing chamber can have only one fluid communication port which is used both for the biological fluid transfer and the extraction of the components.
Multi-port communication is also possible to provide for separate removal of different components.
The transfer of biological fluid into the processing chamber or the extraction of the sub-components does not require any external pump and can be accomplished by the downward and upward movement of a piston into the chamber. Moreover, the volume of the biological fluid processed and volumes of the sub-components extracted can be exactly metered by monitoring the position of the piston into the chamber, like a graduated syringe. The centrifugal processing chamber is self-balanced and therefore can be driven by a compact and lightweight assembly.
The centrifugal processing chamber advantageously has an air pathway allowing movement of the piston without any physical contact of the piston with the centrifuge driving mechanism.
The above-mentioned disposable set is associated with instrumentation which allows processing and separation to take place. The instrumentation is incorporated in a lightweight and portable unit including a centrifuge spinning the processing chamber and valves for directing the components to their appropriate collection container. It is equipped with a sensor system whose information is sent to a central microprocessor unit, allowing full automation of the process.
The description relates principally to the processing and separation of whole blood but the described separation technology can apply to other types of applications like haemapheresis, blood autotransfusion, blood cell washing, or special biological cells isolation like stem cells or islets of Langerhans.
In the case of whole blood donation, this new cell separation system offers significant advantages which include :
• Immediate separation of blood components is obtained during the collection. This suppresses the batch processing of blood units and facilitates the logistics of components preparation.
• Component quality is improved, as immediate separation provides higher cell and protein recovery of blood components. In particular, plasma fractionation efficiency can be significantly improved if freezing of the plasma can occur immediately after the donation.
• The volume of the processing chamber is variable between 0 and the total volume of the chamber (e.g. 500 ml) . It can adapt to any type of donor or patient by suppressing the risks of hypovolemia. It opens up new perspectives in extracorporeal blood treatment for children, for instance. • No pumps are required, but can be used if wanted.
Whole blood is drawn into the chamber through the downward movement of the internal piston and components are collected by moving the piston up again.
• No risks exist of overbleeding a donor as the maximum volume that can be processed is limited by the chamber volume (e.g. 500 ml).
• Volumes of blood processed and components extracted can be accurately measured by monitoring the piston position. No external scale is required.
• Flexible component collection is possible by choosing one or more components and returning the other constituents to the donor.
• The technology is based on conventional medical grade material and manufacturing techniques, which results in a very cost-effective system.
BRIEF DESCRIPTION OF DRAWINGS
The invention will be further described by way of example with reference to the accompanying drawings in which :
- Fig. 1 is a schematic side elevation and cross-sectional view of a processing chamber according to the invention installed in a centrifugal assembly.
- Fig. 2 is a detailed cross-sectional view of the centrifugal processing chamber illustrating the various sedimentation layers of blood components.
- Fig. 3 illustrates in a schematic form the disposable set used for the processing and separation of blood. - Figs. 4.1 to 4.6 are functional diagrams showing the various steps of whole blood separation using a disposable set including a processing chamber according to the invention.
- Fig. 5 is a perspective view of a cabinet containing instrumentation for controlling the processing.
- Fig. 6 is a schematic side elevation and cross-sectional view of a centrifugal assembly.
- Fig. 7 schematically shows an arrangement for controlling pressure in the processing chamber when it is installed in the centrifuge assembly.
- Fig. 8 is a schematic side elevation and cross-sectional view of the upper part of a dual port processing chamber.
- Fig. 9 is a schematic side elevation and cross-sectional view of an extended distribution disk allowing heavier matter to exit the processing chamber first.
- Fig. 10 illustrates in schematic form a system using peristaltic pumps as a means to introduce and extract biological fluids into and out of the processing chamber.
- Fig. 11 illustrates in schematic form a system for intra-operative blood autotransfusion based on the processing chamber with variable volume.
DETAILED DESCRIPTION OF THE SYSTEM
Processing Chamber
The processing chamber 13 in accordance with the embodiment of the invention shown in Figs. 1 and 2 comprises a rotor 4 having a cylindrical shape, in which a piston 5 can move upwards or downwards. A variable separation space 12 is defined between the upper end of the rotor 4 and the piston 5. An inlet/outlet port 2 is located through the upper axis of the rotor 4. It is used both for the introduction of the biological fluid to separate and for the extraction of the separated components out of the chamber 13. The inlet/outlet port 2 is terminated inside the separation space 12 by a disk 3 with passing holes 6 at its lower end. A rotating seal 1 is located at the other end of the inlet/outlet port 2, allowing the connection of tubing lines. Below the piston 5, the bottom cap 9 of rotor 4 has a communication port 7 for air through a central aperture equipped with a bacterial filter 8.
In this embodiment, the rotor 4 is made of a rigid injection molded plastic. A preferable material is polycarbonate or polypropylene which can withstand autoclave sterilization. The upper inlet/outlet port 2 is shown as a separate part fitted on the rotor 4, but it could be an integral part of it . The piston 5 is made of a generally cylindrical disk and is provided with peripheral grooves for O-rings 10. The tightness of these O-rings is chosen such that the piston 5 can be moved for example with vacuum/pressure values comprised in the range between -0.5/+2 bar. This pneumatic embodiment avoids any physical contact between the piston 5 and the associated instrumentation used to drive the processing chamber 13. The bacterial filter 8 ensures that no contamination can be introduced by the air injected to move the piston. Its mesh size is generally about 0.2 microns. It should be noted that the biological fluids never come in contact with the vacuum/pressure space 11 and the bacterial filter 8 provides an additional level of system integrity.
Centrifugation generally starts when the procedure is initiated, although it can begin at a later stage when the processing chamber 13 is partially or totally filled. Initially located in the upper part of rotor 4, the piston 5 will move downward under the effect of the vacuum applied in the vacuum/pressure space 11 through the air communication port 7. The vacuum can be provided through an external air pump, connected to the central axle of the centrifuge driving the processing chamber 13.
The separation space 12 is variable and is comprised between a minimum volume and a maximum corresponding to the volume of the rotor 4. Therefore, minimal quantities of biological fluids can be separated, starting from 10 ml upwards. The biological fluid passes through the rotating seal 1 and penetrates into separation space 12. Its transfer is further helped by an effect of centrifuge pumping, where the liquid introduced under rotation exercices a pressure on piston 5 that increases with the centrifuge speed. By selecting properly the rotational speed when filling, only minimal or even no vacuum is necessary to move the piston 5 down. Centrifugal separation occurs in the space 12 and the piston 5 moves slowly down in order to avoid any disturbance of the sedimentation. Its speed accommodates the donor vein capability by reading the in-line pressure measured in tubing 94 (Fig. 3) and feeding back this information to the control system. Filling rates range between 50-100 ml/min., typically. The speed is selected according to a pressure reading taken by filter 95 which acts as a manometer (Figs. 3 and 7). The residence time and rotational rate are selected such that heavier cellular matter is concentrated at the outer radial region.
As indicated in Fig. 2, the centrifuged biological fluid deposits in distinct layers, with lighter matter moving to the inner region of the separation space 12. Taking blood as an example, these layers are packed red cells 22 on the outside, an intermediate layer 21 of platelets/white cells generally called buffy-coat, and plasma 20 inside.
When the piston 5 reaches the bottom of the rotor 4 (or upon decision of the operator), an additional sedimentation period can be initiated at higher centrifugation speed to accelerate the component separation. The movement of piston 5 can then be inverted by applying a pressure into the vacuum/pressure space 11 through the air communication port 7. The piston 5 moves slowly up again with a speed avoiding any interference with the sedimentation of the components. Lighter matter exits first and will pass through the upper inlet/outlet port 2. Components of increasing density and size will sequentially follow. Heavier matter will finally be expressed and the collection ends when the piston 5 reaches the upper end of the rotor 4. It should be noted that centrifugation can be stopped before the last component is extracted to facilitate its extraction. At that time another processing cycle can resume if desired.
The volume of biological fluid introduced into the processing chamber 13 or the volumes of the extracted components can be exactly measured by monitoring the position of the piston 5 during the process, like a graduated syringe.
Application for Whole Blood Separation
Fig. 3 illustrates an application for whole blood separation. It will be understood however that this is only one example of application of the cell separator and method of the present invention, and other specific applications can be carried out utilizing the invention system.
The disposable set used for this separation comprises a centrifugal processing chamber 13 (like the processing chamber of Figs. 1 and 2) connected to a set of tubing lines and bags. A schematically-indicated phlebotomy needle 82 is connected to a tubing line 93 which connects the processing chamber 13 to a plasma bag 85, a buffy-coat bag 84 and a red cell bag 83. A portion of so-called pigtail tubing 94 terminated with a bacterial filter 95 is connected to the inlet tubing of the processing chamber 13 for pressure measurement (see also Fig. 7).
Anticoagulant like CPD (Citrate-Phosphate-Dextrose) can be contained initially in the plasma bag 83, for transfer into the processing chamber 13 when the procedure is initiated. This is only one way the anticoagulant can be transferred. Alternatives would be to have the processing chamber 13 pre-filled with anticoagulant, or to have an additional bag containing only the anticoagulant. The red cell bag 83 may contain an additive solution to extend the shelf life of erythrocytes.
An optional additional bag 92 contains a special substance for further transfer into the appropriate blood component bags in order to inactivate virus. Another possibility of the system consists in filtering on line components for leukocytes removal, using a filter 91 for the collection of leukocyte-free red cells. Valves 86-90 are associated with the tubing line 93, as illustrated in Fig. 3. These valves are located on the instrument as indicated by reference 102 on Fig. 5, and serve to open/close the tubing lines according to the procedure step.
It should be noted that the bags 83,84,85,92 are not exposed to a stress-causing G force as presently with the batch centrifugation process. The options for design and material choice of the bags are therefore extensive. This facilitates the compliance to regulatory standards for having an environmental friendly disposable material.
The separation of whole blood is sequential and components of increasing density and size are collected.
Separation takes place in six steps illustrated in Figs.
4-1 to 4-6. Centrifugation can start at any time from step 1, 2 or 3. The separation steps are :
Step 1 : Anticoagulant priming of the processing chamber
13 by moving the piston 5 downwards. Valve 89 is open and anticoagulant is pumped out of plasma bag 85. This step can be avoided if the processing chamber is pre-filled with the anticoagulant solution.
Step 2 : Whole blood collection, by moving the piston 5 downwards and opening valve 86.
Step 3 : The piston 5 reaches the bottom of the processing chamber 13, or when stopped by the operator or at a pre-set value. Collection stops. The phlebotomy needle 82 can be disconnected.
Step 4 : Extraction of plasma, by moving the piston 5 upwards. Donor valve 86 is closed, plasma valve 89 is open. Plasma is collected into bag 85.
Step 5 : Buffy-coat extraction, by moving slowly the piston 5 upwards. Plasma valve 89 is closed and buffy-coat valve 88 is open. Buffy-coat is collected into bag 84.
Step 6 : Red cell extraction, by moving the piston 5 upwards. Centrifugation is stopped, although it can be continued if differential separation of red cell collection is desired. Buffy-coat valve 88 is closed and red cell valve 87 is open. Packed red cells are collected into bag 83. Extraction of red cells is completed when the piston reaches the top of the processing chamber
13.
Centrifuge Assembly/Instrumentation
The centrifuge drive unit is illustrated in Fig. 1 with the processing chamber fitted, in Fig. 6 without the processing chamber, and in Fig. 7 with the associated arrangement for controlling pressure. It should be noted that although shown vertically it can be operated in any position.
Referring to Fig. 1, a chuck 46 of generally cylindrical shape with a longitudinal hollow axle 43 underneath is used to drive the centrifuge processing chamber 13. The chuck 46 has an O-ring 51 mounted in an aperture in its bottom. The O-ring 51 frictionally engages the lower outer portion of the air communication port 7 of the inserted processing chamber 13, providing fluid-tight communication with a vacuum/pressure port 36 through which vaccum or air under pressure is supplied from an external source (see Fig. 7). A bearing assembly 35 ensures proper alignment of the chuck 46. Seam rings 47 are located on each side of the bearing assembly 35. Between the two bearings of bearing assembly 35, the axle 43 has a passing hole 44 that communicates with the vacuum/pressure port
36, through a pneumatic path 45.
The chuck 46 is housed within a stationary cylindrical housing 32, which is mounted on a support plate 33. The housing 32 carries a closing cover 31 on its top, along with an associated rotating seal holder 48. The cover 31 is composed of two symmetric planar and semicircular half-discs, that can be moved apart and together so the rotating seal holder 48 can grip the rotating seal 1.
A proximity sensor 50 is secured in the support plate 33 and measures the displacement of the piston 5 for volume and flow rate control. For example, this sensor 50 passes an optical beam through an aperture 49 in the chuck bottom, and which is reflected back by the piston 5. Alternatively, for monitoring the piston displacement, infrared Doppler sensors, inductive or Hall effect sensors could be used.
The pressure/vacuum value in the space 11 is constantly measured by a pressure sensor 72 connected to line 71 (Fig. 7) during operation. The pressure in tubing line 94 is also measured by an in-line pressure sensor 73. This information is fed-back to a control system 74 controlling a compressor driver 75. An algorithm adjusts the power of compressor 70 according to the values of these pressure readings.
The centrifuge is mounted in a cabinet (see Fig. 5) on three cylindrical feet 41. An electrical motor 39 enclosed in a housing 40 with a tachometer 42 fitted on its lower end is attached through a coupling 38 to the chuck axle 43. The rotation speed ranges between about 3000-10000 rpm depending on the application. Motor 39 is mounted on a support shaft plate 37 which is attached to the support plate 33 by shaft housing 34. The processing chamber 13 being self-balanced, the whole centrifuge assembly herein described can be made very light and compact.
As illustrated in Fig. 5, the instrumentation is composed of a cabinet 103 housing a centrifuge 100. It is lightweight and compact which makes this device especially useful for portable applications. The cabinet 103 is made of a reinforced material like ABS. The centrifuge 100 drives the processing chamber 13 at speeds up to 10000 rpm. Valves 102 (i.e. corresponding to 86-90 of Fig. 3) equipped with position sensors are located on the top of the cabinet housing. These valves clamp the proper tubing lines (Fig. 3) for collecting the separated products. Sensors are provided to monitor the pressure inside the processing chamber 13 and piston chambers. An optical sensor 101 controls the appropriate collection of blood constituents like plasma, platelets or red cells and commutes the valves 102 according to the desired separation steps illustrated in Fig. 4-1 to Fig. 6. An ultrasonic air detector 106 monitors the presence of air in the donor line. The cover 104 provides access to the operator-controlled instrumentation. When the cover 104 is open, it is inclined at a 20° angle for ease of viewing. The cover 104 has a panel 107 mounted on the inside with a display and control functions module 105 incorporated therein.
VARIATIONS
The previously-described system uses a single port for transferring fluids in and out of the processing chamber. Fig. 8 shows a dual port configuration allowing a continuous operation, where collection of the desired component can take place while the product to be separated is introduced into the processing chamber. As shown, an inlet port 25 leads onto a distribution disk 27 located at the upper end of chamber 13, so that incoming biological fluid is directed, as indicated by the arrows, to the disk's periphery where the fluid is ejected with the maximum centrifugal force against the chamber wall. An outlet port 26 is located in extension of a central outlet tube 28 leading into the separation space through the center of the distribution disk 27. Consequently, the separated components exit centrally via this tube 28 and outlet port 26, also as indicated by arrows.
In the case of this dual port configuration, continuous operation can be performed using one external pump like the peristaltic pump 110 (Fig. 10) for transferring the biological fluid into chamber 13 via port 25 and distribution disk 27. The piston 5 moves in response to the volume of fluid introduced until the bottom of the chamber is reached, or until stopped at an intermediate position. Two methods can be chosen for extracting the components out of the chamber 13 via tube 28 and port 26. The first consists in continuing filling the chamber so the packed red cells will gradually push the other components out of the chamber 13. The other consists of stopping the peristaltic pump 110, moving the piston 5 up, and the collection of components will be done as illustrated in steps 4-4 to 4-6 of Fig. 4. A multiport system could also be used, where more than one component could be collected out of the chamber simultaneously.
In the described example, the piston 5 is driven by vacuum/compressed air. It would equally be possible to drive the piston by mechanical, electromagnetic or hydraulic means, possibly under electronic control. In the case of hydraulic means, the piston 5 can be moved by sterile fluid that can be pumped in and out of the space 11 of the processing chamber 13.
An alternative would be to have the piston 5 replaced by a flexible and collapsible membrane attached to the upper part of the rotor 4, which can be extended or retracted by application of a vacuum/pressure or by hydraulic action.
In another variation, the rotor 4 of processing chamber 13 can be made of a flexible material like a soft bag which, during rotation, would be supported by the centrifuge chuck 46 so as to maintain a cylindrical shape.
Another variation shown in Fig. 9 consists of having the distribution disk 3 of a diameter close to the internal diameter of rotor 4. When the separated components are expressed out of chamber 13, this would allow the higher density cells like red cells to be sorted first, which would be of interest in red cell autotransfusion for example.
Another variation shown in Fig. 10 consists of transferring fluids in and out of the processing chamber 13 by means of peristaltic pumps 110 and 111 acting on the tubing line 93, respectively to deliver blood into the processing chamber 13 and to remove the separated components from the processing chamber 13. In this case, the piston 5 does not act as a pump, but only as a means to vary the volume of the separation space 12. Consequently it is no longer necessary to use pneumatic means, or any other equivalent means, to move the piston 5. The use of peristaltic pumps is recommended for carrying out haemapheresis procedures, in particular using the dual port arrangement of Fig. 8. Another variation consists of having the upper part of the rotor 4, as well as the upper part of the piston 5, of a conical shape in order to allow a smoother fluid path out of the processing chamber.
OTHER APPLICATIONS
The apparatus of the present invention is particularly suited for the separation and collection of blood components. As described above, a main application is in-line whole blood separation. Other applications include :
1 ) Hemapherssis
It is possible to use the system in an haemapheresis mode where one or more components are returned to the donor or patient. In this case, the instrumentation should incorporate the necessary components and modules to manage the reinfusion procedure. Proper anticoagulation should also be provided at the needle site, with proportional mixing to ensure that no clot formation will occur in the line.
2) Autotransfusion Blood autotransfusion, and more generally cell washing can also be performed with the present invention, as shown in Fig. 11. In the case of intraoperative autotransfusion, shed blood would be aspirated through a line 120 into an autotransfusion reservoir 121 containing a mesh or depth filter 128. The filtered blood could then be transferred into the processing chamber 13 by moving down the piston 5. Supernatant would be expressed out of the chamber 13 in a waste bag 124 and centrifugation would then be stopped. A washing solution contained in bag 125 would be introduced into the processing chamber 13 and centrifugation would resume upon filling of the chamber. Supernatant would be expressed again in bag 124, and another washing step could resume at this stage. Washed red cells would then be recovered in bag 126 by moving up piston 5. Gravity reinfusion would then be initiated to the patient through line 127. The efficiency of this blood autotransfusion system could be advantageously improved by using a dual port configuration chamber as shown in Fig. 8 and a peristaltic pump 110 as shown in Fig. 10.
Post-operative blood autotransfusion would also be possible using the processing chamber 13 in a static mode where only the piston 5 would be moved for establishing the drainage vacuum. Upon filling the processing chamber 13 or completion of the drainage period, centrifugation of the processing chamber 13 would be started and shortly afterwards the piston 5 lifted in order to express the supernatant. Red cells could then be recovered or washed as described above for intraoperative autotransfusion.
3) Cell Isolation
In certain therapeutic applications it is desirable to concentrate specific types of cells such as stem cells, that are present either in the blood or in the bone marrow. In this latter case, the system will function in a batch process and the cells, contained in their physiological medium, would be introduced by moving the piston down. The targeted cells will be expressed out of the processing chamber 13 into the appropriate collection bag. The process is repeated until the initial product has been processed, at which time an ultimate cell purification process can be done by reintroducing the collected cells into the chamber for a final concentration and expressing them into the collection bag.
4) Other Physiological Liquids
In addition to blood, the system can be used for the separation of other physiological fluids such as medium containing islets of Langerhans, or certain type of tumoral cells for further biotechnological manipulations.

Claims

1. A centrifuge apparatus for processing biological fluids, comprising a hollow centrifugal processing chamber
(13) rotatable about an axis of rotation and having an axial inlet/outlet (2) for the biological fluid to be processed and for the processed components of the fluid, characterized in that the processing chamber (13) contains a movable member (5) which defines a separation space (12) of variable size for receiving biological fluid, the member (5) being movable to intake a selected quantity of biological fluid to be processed into the separation chamber (13) via said inlet (2) and to express processed biological fluid components (20,21,22) from the separation chamber (12) via said outlet (2).
2. The apparatus of claim 1, wherein the centrifugal processing chamber (13) is generally cylindrical and the movable member is a piston (5) fluid-tightly movably mounted in the centrifugal processing chamber (13).
3. The apparatus of claim 2, comprising means (70) located externally of the processing chamber (13) for moving the piston (5), there being no physical contact between said means and the piston (5).
4. The apparatus of claim 3, wherein said means (70) acts on the piston (5) via a sterile pneumatic or hydraulic medium.
5. The apparatus of claim 4, wherein the processing chamber (13) comprises an axial opening (7) equipped with a sterile filter (8) adapted for fluid-tight connection of the centrifugal processing chamber (13) to a source (70) of the pneumatic or hydraulic medium.
6. The apparatus of claim 2, comprising means (50) for monitoring the position of the piston (5) to thereby control the amount of intaken biological fluid and the expression of separated components (20,21,22).
7. The apparatus of claim 1, wherein the centrifugal processing chamber (13) has a single inlet/outlet opening (2 ) for both the intake of the biological fluid to be separated and for the removal of separated components (20, 21 , 22) .
8. The apparatus o f claim 1 , wherein the centrifugal processing chamber ( 13 ) has an inlet/outlet
(2 ) comprising one port ( 25 ) for the intake of the biological fluid to be separated and at least one separate port (26 ) for the removal of separated components
(20, 21 , 22) .
9. The apparatus of claim 8, wherein the inlet port (25) for biological fluid cooperates with a distribution disk (27) directing the incoming fluid to the periphery thereof where the fluid is exposed to the maximum centrifugal force.
10. The apparatus of claim 1, further comprising a drive unit for the centrifugal processing chamber (13), said drive unit comprising a rotary chuck (46) for receiving the centrifugal processing chamber (13), the chuck (46) being rotatably mounted inside a stationary housing (32) and connected via a pneumatic or hydraulic path (45) to an external source (70) of pneumatic or hydraulic medium, the stationary housing (32) having a cover (31) with an aperture (48) receiving means (1) for rotatably mounting the inlet/outlet (2) of the centrifugal processing chamber (13).
11. A disposable set for collecting and separating selected quantities of biological fluids comprising the centrifugal processing chamber (13) of an apparatus according to any one of claims 1 to 10, wherein the inlet/outlet (2) of the centrifugal processing chamber
(13) is connected to a means (82) for collecting biological fluid and to a plurality of containers
(83,84,85,92) for receiving the separated components
(20,21,22) of the biological fluid.
12. The disposable set according to claim 11, wherein the means (82) for collecting biological fluid is associated with a valve (86), and each of said containers (83,84,85,92) is associated with a valve (87,88,89,90).
13. The disposable set according to claim 11, further comprising at least one filter (91) for on-line filtering of separated components.
14. A centrifuge apparatus for processing biological fluids using a disposable set as claimed in claim 12, wherein the apparatus further comprises means for selectively actuating the valve (86) and the valves (87,88,89,90) to control intake of biological fluid into the centrifugal processing chamber (13) and delivery of the expressed separate components (20,21,22) of the biological fluid into respective containers (83,84,85,92).
15. A method of processing biological fluids in an apparatus according to any one of claims 1 to 10, comprising intaking a selected variable quantity of biological fluid into the separation space (12) with corresponding movement of the movable member (5), centrifuging the biological fluid in the separation space
(12) during and/or after intaking the fluid, and moving the member (5) back to express the centrifuged fluid components via the outlet (2).
16. The method of claim 15, wherein the movable member is a piston (5), and wherein movement of the piston
(5) is controlled by pneumatic or hydraulic means to select the volume of biological fluid intaken into the separation space and to selectively express the separated components (20,21,22).
17. The method of claim 16, wherein movement of the piston (5) to intake biological fluid is assisted by a centrifugal pumping effect produced by pressure exerted on the piston (5) by the the incoming biological fluid.
18. The method of claim 16 or 17, comprising monitoring the position of the piston (5) to intake a selected variable quantity of biological fluid and to selectively express the separated components (20,21,22).
19. The method of any one of claims 15 to 18, wherein the intaken fluid is drawn from a blood autotransfusion reservoir (121); supernatant and washed solution are expressed in a waste container (124); and red cells are expressed in a collection container (126); all by moving the movable member (5).
20. Use of the apparatus of any one of claims 1 to 10, or of the disposable set of any one of claims 11 to 14, for processing variable volumes of biological fluid from 10 ml up to the maximum volume of the separation chamber (12).
21. Use according to claim 20 for whole blood collection and separation.
22. Use according to claim 20 for shed blood washing and recovery.
PCT/IB1996/000771 1996-04-24 1996-08-02 Cell separation system for biological fluids like blood WO1997015399A1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
EP96924105A EP0912250B1 (en) 1996-04-24 1996-08-02 Cell separation system for biological fluids like blood
US09/147,117 US6123655A (en) 1996-04-24 1996-08-02 Cell separation system with variable size chamber for the processing of biological fluids
DE69605062T DE69605062T2 (en) 1996-04-24 1996-08-02 CELL SEPARATION DEVICE FOR BIOLOGICAL LIQUIDS LIKE BLOOD
AU64677/96A AU6467796A (en) 1996-04-24 1996-08-02 Cell separation system for biological fluids like blood

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ATPCT/IB96/00373 1996-04-24
IB9600373 1996-04-24

Publications (1)

Publication Number Publication Date
WO1997015399A1 true WO1997015399A1 (en) 1997-05-01

Family

ID=11004420

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB1996/000771 WO1997015399A1 (en) 1996-04-24 1996-08-02 Cell separation system for biological fluids like blood

Country Status (6)

Country Link
US (1) US6123655A (en)
EP (1) EP0912250B1 (en)
AT (1) ATE186235T1 (en)
AU (1) AU6467796A (en)
DE (1) DE69605062T2 (en)
WO (1) WO1997015399A1 (en)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000038762A1 (en) * 1998-12-24 2000-07-06 Biosafe S.A. Blood separation system particularly for concentrating hematopoietic stem cells
WO2000045931A1 (en) * 1999-02-06 2000-08-10 Frymate Limited Apparatus for separating solids from oil
WO2003009889A1 (en) * 2001-07-26 2003-02-06 Cellgenix Technologie Transfer Gmbh Method for enriching cells
US6964646B1 (en) 1999-08-12 2005-11-15 Fresenius Hemocare Gmbh Device and method for autologous blood transfusion
JP2006305365A (en) * 2005-04-27 2006-11-09 Biomet Manufacturing Corp Method and apparatus for producing autoclotting component
EP1920792A1 (en) * 2002-04-16 2008-05-14 Gambro BCT, Inc. Method of determining a location of an interface during processing of blood components
US9566540B2 (en) 2011-03-29 2017-02-14 Emd Millipore Corporation Method and device for centrifugation and filtration
JP2018502634A (en) * 2014-12-19 2018-02-01 ビオセフ エス・アー Continuous treatment of biological fluids
US10449555B2 (en) * 2017-05-16 2019-10-22 Robert Bret Carr Centrifugal separator with annular piston for solids extrusion

Families Citing this family (109)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6695951B1 (en) 2000-07-18 2004-02-24 Jack G. Bitterly Saline/sewage water reclamation system
GB0118742D0 (en) * 2001-08-01 2001-09-26 Jeory James A coupling
US7479123B2 (en) 2002-03-04 2009-01-20 Therakos, Inc. Method for collecting a desired blood component and performing a photopheresis treatment
US7211037B2 (en) 2002-03-04 2007-05-01 Therakos, Inc. Apparatus for the continuous separation of biological fluids into components and method of using same
US7832566B2 (en) 2002-05-24 2010-11-16 Biomet Biologics, Llc Method and apparatus for separating and concentrating a component from a multi-component material including macroparticles
US7992725B2 (en) 2002-05-03 2011-08-09 Biomet Biologics, Llc Buoy suspension fractionation system
US20030205538A1 (en) 2002-05-03 2003-11-06 Randel Dorian Methods and apparatus for isolating platelets from blood
US7179391B2 (en) * 2002-05-24 2007-02-20 Biomet Manufacturing Corp. Apparatus and method for separating and concentrating fluids containing multiple components
US7845499B2 (en) 2002-05-24 2010-12-07 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US20060278588A1 (en) 2002-05-24 2006-12-14 Woodell-May Jennifer E Apparatus and method for separating and concentrating fluids containing multiple components
ITMI20031715A1 (en) * 2003-09-05 2005-03-06 Dideco Spa CONTROL DEVICE IN THE DIFFERENTIATED COLLECTION OF THE
US7060018B2 (en) * 2003-09-11 2006-06-13 Cobe Cardiovascular, Inc. Centrifuge apparatus for processing blood
EP1683579A1 (en) * 2005-01-25 2006-07-26 Jean-Denis Rochat Disposable device for the continuous separation by centrifugation of a physiological liquid
US7442178B2 (en) 2005-03-09 2008-10-28 Jacques Chammas Automated system and method for blood components separation and processing
KR101319135B1 (en) * 2005-03-23 2013-10-17 바이오세이프 쏘시에떼아노님 Integrated System for Collecting, Processing and Transplanting Cell Subsets, including Adult Stem Cells, for Regenerative Medicine
US7364657B2 (en) * 2005-03-31 2008-04-29 Abbott Cardiovascular Systems Inc. Integrated system for on-site cell acquisition, processing, and delivery
US7618361B2 (en) * 2005-09-01 2009-11-17 Wagner Development, Inc. Gas driven solids discharge and pumping piston for a centrifugal separator
US7998052B2 (en) * 2006-03-07 2011-08-16 Jacques Chammas Rotor defining a fluid separation chamber of varying volume
GB0608451D0 (en) * 2006-04-28 2006-06-07 Ge Healthcare Bio Sciences Ab Centrifugal separation system
US8567609B2 (en) 2006-05-25 2013-10-29 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US8328024B2 (en) 2007-04-12 2012-12-11 Hanuman, Llc Buoy suspension fractionation system
US7806276B2 (en) 2007-04-12 2010-10-05 Hanuman, Llc Buoy suspension fractionation system
EP2259774B1 (en) 2008-02-27 2012-12-12 Biomet Biologics, LLC Methods and compositions for delivering interleukin-1 receptor antagonist
WO2009111338A1 (en) 2008-02-29 2009-09-11 Biomet Manufacturing Corp. A system and process for separating a material
US20100112696A1 (en) * 2008-11-03 2010-05-06 Baxter International Inc. Apparatus And Methods For Processing Tissue To Release Cells
AU2013204205B2 (en) * 2008-12-01 2015-09-24 Baxalta GmbH Apparatus and method for processing biological material
US8309343B2 (en) 2008-12-01 2012-11-13 Baxter International Inc. Apparatus and method for processing biological material
US8177072B2 (en) * 2008-12-04 2012-05-15 Thermogenesis Corp. Apparatus and method for separating and isolating components of a biological fluid
JP5688374B2 (en) * 2008-12-29 2015-03-25 ワグナー デベロップメント, インコーポレイテッド Solid discharge centrifuge with disposable contact element
US8187475B2 (en) 2009-03-06 2012-05-29 Biomet Biologics, Llc Method and apparatus for producing autologous thrombin
US8313954B2 (en) 2009-04-03 2012-11-20 Biomet Biologics, Llc All-in-one means of separating blood components
US9272083B2 (en) 2009-05-29 2016-03-01 Endocellutions, Inc. Apparatus and methods for aspirating and separating components of different densities from a physiological fluid containing cells
US9011800B2 (en) 2009-07-16 2015-04-21 Biomet Biologics, Llc Method and apparatus for separating biological materials
US9034280B2 (en) 2009-12-16 2015-05-19 General Electric Corporation High-throughput methods and systems for processing biological materials
US8591391B2 (en) 2010-04-12 2013-11-26 Biomet Biologics, Llc Method and apparatus for separating a material
US8870733B2 (en) 2010-11-19 2014-10-28 Kensey Nash Corporation Centrifuge
US8469871B2 (en) 2010-11-19 2013-06-25 Kensey Nash Corporation Centrifuge
US8556794B2 (en) 2010-11-19 2013-10-15 Kensey Nash Corporation Centrifuge
US8317672B2 (en) 2010-11-19 2012-11-27 Kensey Nash Corporation Centrifuge method and apparatus
US8394006B2 (en) 2010-11-19 2013-03-12 Kensey Nash Corporation Centrifuge
US9642956B2 (en) 2012-08-27 2017-05-09 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
WO2014120797A1 (en) 2013-01-29 2014-08-07 Endocellutions, Inc. Cell concentration devices and methods
US20140271589A1 (en) 2013-03-15 2014-09-18 Biomet Biologics, Llc Treatment of collagen defects using protein solutions
US10208095B2 (en) 2013-03-15 2019-02-19 Biomet Manufacturing, Llc Methods for making cytokine compositions from tissues using non-centrifugal methods
US9895418B2 (en) 2013-03-15 2018-02-20 Biomet Biologics, Llc Treatment of peripheral vascular disease using protein solutions
US9950035B2 (en) 2013-03-15 2018-04-24 Biomet Biologics, Llc Methods and non-immunogenic compositions for treating inflammatory disorders
US10143725B2 (en) 2013-03-15 2018-12-04 Biomet Biologics, Llc Treatment of pain using protein solutions
ES2424272B1 (en) * 2013-07-23 2014-01-29 Riera Nadeu, S.A. Supercentrifuge with non-intrusive solid extraction device and its extraction procedure
EP3660140A1 (en) 2014-01-31 2020-06-03 DSM IP Assets B.V. Adipose tissue processing centrifuge and methods of use
KR101466762B1 (en) * 2014-03-28 2014-11-28 이준석 Central seperator and central seperating method and bowl for central seperator
EP3151970B1 (en) 2014-06-04 2018-08-15 Biosafe S.A. System for multi-processing and separation of biological fluids
TW202315948A (en) * 2014-11-05 2023-04-16 美商奇諾治療有限公司 Methods for transduction and cell processing
BR112017022530B1 (en) 2015-05-07 2021-06-29 Biosafe S.A. DEVICE, SYSTEM AND METHOD FOR THE CONTINUOUS PROCESSING AND SEPARATION OF BIOLOGICAL FLUIDS INTO COMPONENTS
GB201511039D0 (en) * 2015-06-23 2015-08-05 Karhiniemi Marko And Medigoo Oy And Karilahti Mika In-vitro-analyser
AU2017301887A1 (en) 2016-07-29 2019-02-07 Juno Therapeutics, Inc. Anti-idiotypic antibodies against anti-CD19 antibodies
EP3510136A1 (en) 2016-09-12 2019-07-17 Juno Therapeutics, Inc. Perfusion bioreactor bag assemblies
CA3045338A1 (en) 2016-12-05 2018-06-14 Juno Therapeutics, Inc. Production of engineered cells for adoptive cell therapy
WO2018157171A2 (en) 2017-02-27 2018-08-30 Juno Therapeutics, Inc. Compositions, articles of manufacture and methods related to dosing in cell therapy
EP3634637A4 (en) * 2017-06-08 2021-03-03 Patrick Pennie Dual piston centrifuge tube
CA3070573A1 (en) 2017-07-29 2019-02-07 Juno Therapeutics, Inc. Reagents for expanding cells expressing recombinant receptors
GB201713252D0 (en) * 2017-08-18 2017-10-04 Biosafe Sa Piston movement
KR20230092033A (en) 2017-09-01 2023-06-23 론차 콜로그네 게엠베하 End-to-End Cell Therapy Automation
WO2019051335A1 (en) 2017-09-07 2019-03-14 Juno Therapeutics, Inc. Methods of identifying cellular attributes related to outcomes associated with cell therapy
CN111542596A (en) 2017-11-01 2020-08-14 朱诺治疗学股份有限公司 Methods of producing therapeutic compositions of engineered cells
AU2018360801A1 (en) 2017-11-01 2020-05-14 Celgene Corporation Process for producing a T cell composition
CN111556789A (en) 2017-11-10 2020-08-18 朱诺治疗学股份有限公司 Closed system cryogenic vessel
KR20200108277A (en) 2017-12-08 2020-09-17 주노 쎄러퓨티크스 인코퍼레이티드 Serum-free medium formulation for culturing cells and methods of use thereof
CN112004824A (en) 2017-12-08 2020-11-27 朱诺治疗学股份有限公司 Process for producing engineered T cell compositions
CA3084446A1 (en) 2017-12-08 2019-06-13 Juno Therapeutics, Inc. Phenotypic markers for cell therapy and related methods
EP3784363A4 (en) 2018-07-09 2022-02-16 Hanuman Pelican, Inc. Apparatus and methods for separating blood components
JP2021531059A (en) 2018-07-09 2021-11-18 ハヌマン ペリカン,インコーポレイテッド Equipment and methods for processing blood
BR112021002245A2 (en) 2018-08-09 2021-05-04 Juno Therapeutics Inc methods for evaluating integrated nucleic acids
WO2020033927A2 (en) 2018-08-09 2020-02-13 Juno Therapeutics, Inc. Processes for generating engineered cells and compositions thereof
MX2021002574A (en) 2018-09-11 2021-06-08 Juno Therapeutics Inc Methods for mass spectrometry analysis of engineered cell compositions.
WO2020089343A1 (en) 2018-10-31 2020-05-07 Juno Therapeutics Gmbh Methods for selection and stimulation of cells and apparatus for same
JP2022512917A (en) 2018-11-01 2022-02-07 ジュノー セラピューティクス インコーポレイテッド Treatment method using a chimeric antigen receptor specific for B cell maturation antigen
US20210393691A1 (en) 2018-11-06 2021-12-23 Juno Therapeutics, Inc. Process for producing genetically engineered t cells
CN113271963A (en) 2018-11-16 2021-08-17 朱诺治疗学股份有限公司 Methods of administering engineered T cells for treatment of B cell malignancies
JP2022513689A (en) 2018-11-30 2022-02-09 ジュノー セラピューティクス インコーポレイテッド Methods for Administration and Treatment of B-Cell Malignancies in Adoptive Cell Therapy
CA3120869A1 (en) 2018-11-30 2020-06-04 Juno Therapeutics, Inc. Methods for treatment using adoptive cell therapy
SG11202106384YA (en) 2018-12-21 2021-07-29 Octane Biotech Inc Carousel for modular biologic production units
KR20210108406A (en) 2018-12-21 2021-09-02 론자 워커스빌 아이엔씨. Automated production of viral vectors
US20220088589A1 (en) 2019-01-21 2022-03-24 Eclipse Medcorp, Llc Methods, Systems and Apparatus for Separating Components of a Biological Sample
EP3890799A4 (en) 2019-02-06 2022-10-26 Hanuman Pelican, Inc. Apparatus and methods for concentrating platelet-rich plasma
US11773365B2 (en) 2019-02-08 2023-10-03 Lonza Walkersville, Inc. Cell concentration methods and devices for use in automated bioreactors
KR20220034782A (en) 2019-06-12 2022-03-18 주노 쎄러퓨티크스 인코퍼레이티드 Combination therapy of cell-mediated cytotoxicity therapy and pro-survival BLC2 family protein inhibitors
US20220298222A1 (en) 2019-08-22 2022-09-22 Juno Therapeutics, Inc. Combination therapy of a t cell therapy and an enhancer of zeste homolog 2 (ezh2) inhibitor and related methods
WO2021041994A2 (en) 2019-08-30 2021-03-04 Juno Therapeutics, Inc. Machine learning methods for classifying cells
EP4051402A1 (en) 2019-10-30 2022-09-07 Juno Therapeutics GmbH Cell selection and/or stimulation devices and methods of use
JP2022554348A (en) 2019-11-05 2022-12-28 ジュノー セラピューティクス インコーポレイテッド Methods of Determining Attributes of Therapeutic T Cell Compositions
JP2023504740A (en) 2019-12-06 2023-02-06 ジュノー セラピューティクス インコーポレイテッド Anti-idiotypic antibodies against BCMA target binding domains and related compositions and methods
US20230053787A1 (en) 2019-12-06 2023-02-23 Juno Therapeutics, Inc. Methods related to toxicity and response associated with cell therapy for treating b cell malignancies
WO2021113780A1 (en) 2019-12-06 2021-06-10 Juno Therapeutics, Inc. Anti-idiotypic antibodies to gprc5d-targeted binding domains and related compositions and methods
BR112022014501A2 (en) 2020-01-24 2022-09-20 Juno Therapeutics Inc METHODS FOR DOSING AND TREATMENT OF FOLLICULAR LYMPHOMA AND MARGINAL ZONE LYMPHOMA IN ADOPTIVE CELL THERAPY
KR20220146480A (en) 2020-01-28 2022-11-01 주노 쎄러퓨티크스 인코퍼레이티드 T cell transduction method
MX2022009830A (en) 2020-02-12 2022-10-28 Juno Therapeutics Inc Bcma-directed chimeric antigen receptor t cell compositions and methods and uses thereof.
US20230190798A1 (en) 2020-02-12 2023-06-22 Juno Therapeutics, Inc. Cd19-directed chimeric antigen receptor t cell compositions and methods and uses thereof
MX2022012533A (en) 2020-04-10 2022-12-13 Juno Therapeutics Inc Methods and uses related to cell therapy engineered with a chimeric antigen receptor targeting b-cell maturation antigen.
KR20230024283A (en) 2020-05-13 2023-02-20 주노 쎄러퓨티크스 인코퍼레이티드 Methods for identifying features associated with clinical response and uses thereof
CN115835873A (en) 2020-05-13 2023-03-21 朱诺治疗学股份有限公司 Method for generating donor batch cells expressing recombinant receptor
US11738288B2 (en) 2020-06-29 2023-08-29 Jacques Chammas Automated system and method to isolate specific cells from blood or bone marrow
WO2022029660A1 (en) 2020-08-05 2022-02-10 Juno Therapeutics, Inc. Anti-idiotypic antibodies to ror1-targeted binding domains and related compositions and methods
WO2022133030A1 (en) 2020-12-16 2022-06-23 Juno Therapeutics, Inc. Combination therapy of a cell therapy and a bcl2 inhibitor
AU2022241654A1 (en) 2021-03-22 2023-09-28 Juno Therapeutics, Inc. Methods of determining potency of a therapeutic cell composition
AU2022244229A1 (en) 2021-03-22 2023-09-14 Juno Therapeutics, Inc. Method to assess potency of viral vector particles
AU2022246593A1 (en) 2021-03-29 2023-10-12 Juno Therapeutics, Inc. Methods for dosing and treatment with a combination of a checkpoint inhibitor therapy and a car t cell therapy
WO2023230581A1 (en) 2022-05-25 2023-11-30 Celgene Corporation Methods of manufacturing t cell therapies
WO2023230548A1 (en) 2022-05-25 2023-11-30 Celgene Corporation Method for predicting response to a t cell therapy
WO2023250400A1 (en) 2022-06-22 2023-12-28 Juno Therapeutics, Inc. Treatment methods for second line therapy of cd19-targeted car t cells

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3104225A (en) * 1960-01-29 1963-09-17 Lourdes Instr Corp Continuous flow centrifuge rotor and liner element
EP0027476A1 (en) * 1979-10-19 1981-04-29 Otto Wimmer Centrifuge
WO1985002560A1 (en) * 1983-12-13 1985-06-20 Baxter Travenol Laboratories, Inc. Centrifuge with movable mandrel
US5316540A (en) * 1993-01-13 1994-05-31 Cobe Laboratories Apparatus and method for separating microscopic units in a substantially continuous density gradient solution
EP0654669A2 (en) * 1993-11-19 1995-05-24 Bristol-Myers Squibb Company Liquid separation apparatus and method

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2661150A (en) * 1947-12-17 1953-12-01 Jr William G Abbott Centrifuge
US3239136A (en) * 1962-05-07 1966-03-08 George N Hein Centrifuge and centrifuge head for separating constituents of a liquid and a liner therefor
US3096283A (en) * 1959-06-24 1963-07-02 Becton Dickinson Co Container for blood and machine for separating precipitates from liquid blood constituents
UST955355I4 (en) * 1959-06-24 1900-01-01
US3456875A (en) * 1966-08-18 1969-07-22 George N Hein Air driven centrifuge
US3737096A (en) * 1971-12-23 1973-06-05 Ibm Blood processing control apparatus
US4142670A (en) * 1978-01-27 1979-03-06 Beckman Instruments, Inc. Chylomicron rotor
US4303193A (en) * 1979-01-22 1981-12-01 Haemonetics Corporation Apparatus for separating blood into components thereof
US4889524A (en) * 1987-09-04 1989-12-26 Haemonetics Corporation Portable centrifuge apparatus
US5733253A (en) * 1994-10-13 1998-03-31 Transfusion Technologies Corporation Fluid separation system
US5728040A (en) * 1996-09-09 1998-03-17 Schill Enterprises, Inc. Variable volume cell saver bowl

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3104225A (en) * 1960-01-29 1963-09-17 Lourdes Instr Corp Continuous flow centrifuge rotor and liner element
EP0027476A1 (en) * 1979-10-19 1981-04-29 Otto Wimmer Centrifuge
WO1985002560A1 (en) * 1983-12-13 1985-06-20 Baxter Travenol Laboratories, Inc. Centrifuge with movable mandrel
US5316540A (en) * 1993-01-13 1994-05-31 Cobe Laboratories Apparatus and method for separating microscopic units in a substantially continuous density gradient solution
EP0654669A2 (en) * 1993-11-19 1995-05-24 Bristol-Myers Squibb Company Liquid separation apparatus and method

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000038762A1 (en) * 1998-12-24 2000-07-06 Biosafe S.A. Blood separation system particularly for concentrating hematopoietic stem cells
JP2002533171A (en) * 1998-12-24 2002-10-08 ビオセフ エス・アー Blood separation device specialized for enriching hematopoietic stem cells
US6733433B1 (en) 1998-12-24 2004-05-11 Biosafe S.A. Blood separation system particularly for concentrating hematopoietic stem cells
WO2000045931A1 (en) * 1999-02-06 2000-08-10 Frymate Limited Apparatus for separating solids from oil
US6964646B1 (en) 1999-08-12 2005-11-15 Fresenius Hemocare Gmbh Device and method for autologous blood transfusion
EP1075844B1 (en) * 1999-08-12 2006-10-04 Fresenius AG Device for autologous blood transfusion
WO2003009889A1 (en) * 2001-07-26 2003-02-06 Cellgenix Technologie Transfer Gmbh Method for enriching cells
EP1920792A1 (en) * 2002-04-16 2008-05-14 Gambro BCT, Inc. Method of determining a location of an interface during processing of blood components
JP2006305365A (en) * 2005-04-27 2006-11-09 Biomet Manufacturing Corp Method and apparatus for producing autoclotting component
US9566540B2 (en) 2011-03-29 2017-02-14 Emd Millipore Corporation Method and device for centrifugation and filtration
JP2018502634A (en) * 2014-12-19 2018-02-01 ビオセフ エス・アー Continuous treatment of biological fluids
US10449555B2 (en) * 2017-05-16 2019-10-22 Robert Bret Carr Centrifugal separator with annular piston for solids extrusion

Also Published As

Publication number Publication date
EP0912250A1 (en) 1999-05-06
DE69605062D1 (en) 1999-12-09
EP0912250B1 (en) 1999-11-03
US6123655A (en) 2000-09-26
DE69605062T2 (en) 2000-07-13
AU6467796A (en) 1997-05-15
ATE186235T1 (en) 1999-11-15

Similar Documents

Publication Publication Date Title
US6123655A (en) Cell separation system with variable size chamber for the processing of biological fluids
US5853382A (en) Blood collection and separation process
CA2452055C (en) Integrated automatic blood collection and processing unit
US6709412B2 (en) Blood processing systems and methods that employ an in-line leukofilter mounted in a restraining fixture
US20050124927A1 (en) Blood processing systems and methods that alternate flow of blood component and additive solution through an in-line leukofilter
EP2515966B1 (en) Methods and apparatus for collection of filtered blood components, in particular red blood cells
AU2002327241A1 (en) Integrated automatic blood collection and processing unit
JPH01502029A (en) centrifugal pheresis system
US20160279315A1 (en) Device for separating blood into its components as well as a method for doing so and use of such a device
US20040217069A1 (en) Rotor assembly for the collection, separation, and sampling of rare blood cells
US20020077582A1 (en) Blood processing systems and methods that assess and respond to real or potential vein occlusion conditions
US20020094927A1 (en) Blood separation systems and methods with umbilicus-driven blood separation chambers
AU718172B2 (en) Method of collecting and processing blood

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AL AM AT AU AZ BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE HU IL IS JP KE KG KP KR KZ LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US UZ VN AM AZ BY KG KZ MD RU TJ TM

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 09147117

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 1996924105

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

NENP Non-entry into the national phase

Ref country code: JP

Ref document number: 97516421

Format of ref document f/p: F

WWP Wipo information: published in national office

Ref document number: 1996924105

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: CA

WWG Wipo information: grant in national office

Ref document number: 1996924105

Country of ref document: EP